<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2347">
<titleInfo>
<title>European Journal of Pharmaceutical Sciences 1 January 2023</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher></publisher>
<dateIssued>2023</dateIssued>
<issuance>monographic</issuance>
<edition>January 2023</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Jurnal</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT
The ocular delivery route presents a number of challenges in terms of drug administration and bioavailability.
The low bioavailability following topical ophthalmic administration shows that there is a clear need for in-depth
research aimed at finding both more efficacious molecules and formulations precisely targeted at the site of
action. Continuous technological development will eventually result in improved bioavailability, lower dosages,
reduced toxicity, fewer adverse effects, and thus better patient compliance and treatment efficacy. Technological
development, as well as increasingly stringent quality requirements, help stimulate analytical progress. This is
also clearly evident in the case of medicinal products used in the treatment of glaucoma, which are the subject of
this review. Impurity profiling of PGF2&alpha; analogues, either in the pure substance or in the finished formulation, is
a crucial step in assessing their quality. The development of specific, accurate and precise stability-indicating

analytical methods for determining the content and related substances seems to be an important issue in rela-
tion to this tasks. A total of 27 official and in-house analytical methods are presented that are used for the

analysis of latanoprost, travoprost and bimatoprost. The conditions for chromatographic separation with UV or
MS/MS detection and the available results obtained during method validation are described. In addition, several
aspects are discussed, with particular emphasis on the instability of the analogues in aqueous solution and the
phenomenon of isomerism, which affects a potentially large number of degradation products.</note>
<subject authority=""><topic>Prostaglandin analogue</topic></subject>
<subject authority=""><topic>Glaucoma</topic></subject>
<subject authority=""><topic>Analytical method</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0130</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Farmasi Internasional)</sublocation>
<shelfLocator>615 ASI</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2219" url="https://drive.google.com/file/d/1YybxHd9oETIfp7rOrT59XGyFZ0VVOCeI/view?usp=sharing" path="/https://drive.google.com/file/d/1YybxHd9oETIfp7rOrT59XGyFZ0VVOCeI/view?usp=sharing" mimetype="text/uri-list">1 January 2023</slims:digital_item>
</slims:digitals><slims:image>1_January_2023.jpeg.jpeg</slims:image>
<recordInfo>
<recordIdentifier>2347</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2026-07-10 13:32:13</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2026-07-13 07:12:38</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>